Supplements

“Aker BioMarine has appointed a talented leader with a vision of how to take the company into the future.”

Norwegian krill player appoints new chief

By Shane Starling

Matts Johansen has been appointed CEO of krill major Aker BioMarine with a mandate to “to continue to develop one of Norway's most exciting biotechnology companies into a solid and predictable company”.

The problem with botanicals is just a matter of colliding cultures, industry interests and of process, says managing director for Italian-based Hylobates Consulting

It's time to end EU’s botanical Babel, says expert

By Luca Bucchini, Hylobates Consulting managing director

The EU is old enough and ugly enough to get itself out of its botanical rut, so what's the hold up? Dr Luca Bucchini, managing director of Hylobates Consulting, asks.

Blackmores: We wanted to see krill sustainability with our own eyes

Dispatches from Vitafoods Europe

Blackmores: We wanted to see krill sustainability with our own eyes

By Hank Schultz

Blackmores, the leading supplement brand in Australia, has taken the unusual step of sending a company representative on a two week-long trip to verify the sustainability practices of Aker BioMarine, the world’s largest harvester of krill used to supply...

Tablet tiredness: Probiotic chocolate could be attractive supplement alternative, claims Milsing.

Special edition: Innovations in better-for-you confectionery

Probiotics more stable in chocolate than pills, says Milsing

By Oliver Nieburg

Chocolate is a more effective delivery system than capsules and tablets for probiotics and could be an attractive alternative for consumers, according to Croatian supplement firm Milsing.

Norway prepares for regulation on 'other substances' in food supplements

Norway looks at 44 unregulated 'other substances'

By Annie Harrison-Dunn

The Norwegian Food Safety Authority (NFSA) has asked its scientific committee to assess the safety of 'other substances' found on the Norwegian market - something it says is "largely unregulated" at EU level.

Chia claims as they stand on the WFH home page today

ASA ruling

Healthy water slugged over claims abuse

By Shane STARLING

Scotland-based supplement and infused water distributor Water for Health (WFH) has been censored by the UK Advertising Standards Authority (ASA) for making non-authorised immunity and other claims for chlorella and other infusions in the European Union.

71% of the Danish participants had used at least one dietary supplement during the previous 12 months.

Which came first, the health or the supplement?

By Annie Harrison-Dunn

The healthier a person is the more likely they are to take food supplements – which could distort links between the products and health outcomes, say Danish researchers.

Too much? Or is the food industry not doing enough?

Free NutraIngredients and FoodNavigator online event - June 3, 14:00 Paris time

Big debates, big issues: Is the food industry winning the war against weight?

By Shane STARLING

As the ‘globesity’ health footprint grows and power weight management brands struggle to stay relevant in an age where smartphone apps deliver personalised solutions, join us next week for a free online event, where key issues will be debated.

Peter Zambetti:

Special edition: Outsourcing

Collaborate or die: Inside a contract manufacturing giant

By Shane STARLING

What does it take to be a successful contract manufacturer and solutions provider to the food supplements sector in an age where the sanctity of many business coalitions is being challenged by nimble start-ups with an array of new post-capitalist tools? We...

Vitafoods Europe 2015: 15,627 visitors from around Europe and the globe

Visitors from 101 countries

Vitafoods Europe breaks records (again)

Show traffic was up 12.5% at Vitafoods Europe this year meaning record numbers visited the 800+ suppliers and brands at the 3-day Geneva expo and conference.

Should vitamin K2 also be recommended for statin users?

Should vitamin K2 also be recommended for statin users?

By Stephen DANIELLS

Statins may be “mitochondrial toxins”, says a new review that finds that the pharmaceuticals may not only deplete CoQ10 levels but also inhibit the synthesis of vitamin K2. The result could be negative effects on the heart and blood vessels.

Follow us

Products

View more

Webinars